Newsroom | 26960 results

Sorted by: Latest

Hospitals
-

Prime Healthcare Services, Inc. Schedules 2026 1st Quarter Earnings Conference Call

ONTARIO, Calif.--(BUSINESS WIRE)--Prime Healthcare Services will report earnings the morning of May 12th, 2026, to be followed by a conference call at 2:00 p.m. (ET) to discuss the reported results. To pre-register prior to the call, email EGarcia27@primehealthcare.com to facilitate attaining your individual pin that will allow direct access to the call. About Prime Healthcare and Prime Healthcare Foundation Prime Healthcare is an award-winning health system operating 54 hospitals and more than...
-

Retractable Technologies, Inc. Announces Workforce Reduction

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that it has reduced its workforce by approximately 16%. The reduction is expected to save an estimated $2.2 million in annual wages and employment benefits, or approximately 13% of total estimated workforce costs. The expected savings are offset by estimated one-time separation payments of approximately $122 thousand to the affected workers. Approximately 58% of the targeted payroll reduction affects...
-

Concentra to Announce First Quarter 2026 Results on Thursday, May 7, 2026

ADDISON, Texas--(BUSINESS WIRE)--Concentra® Group Holdings Parent, Inc. (“Concentra”) (NYSE: CON) will release the financial results for its first quarter ended March 31, 2026, on Thursday, May 7, 2026, after the market closes. Concentra will host a conference call regarding its financial results on Friday, May 8, 2026, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra’s website at https://ir.concentra.com...
-

BoxSPINE Receives FDA Clearance for Rodless Spinal Fixation System, Redefining a Decades-Old Surgical Approach

WINONA LAKE, Ind. & PLYMOUTH, Ind.--(BUSINESS WIRE)--BoxSPINE Receives FDA Clearance for Rodless Spinal Fixation System, The DUET™ Spinal Fixation System, Redefining a Decades-Old Surgical Approach....
-

Bain Capital and Evergreen Medical Properties Acquire Portfolio of Six Medical Outpatient Facilities in Atlanta Metropolitan Area

ATLANTA & BOSTON--(BUSINESS WIRE)--Bain Capital's Real Estate team ("Bain Capital") and Evergreen Medical Properties (“Evergreen”) today announced the acquisition of a medical outpatient building portfolio consisting of six assets totaling approximately 665,000 square feet in the Atlanta metropolitan area. The private, off-market purchase was completed via a partnership between Bain Capital and Evergreen that focuses on acquiring, renovating, and operating mission-critical medical outpatient bu...
-

Qventus Releases Second Annual CIO Report Revealing How Health Systems Are Closing the Gap Between AI Pilots and Payoff

SAN FRANCISCO--(BUSINESS WIRE)--Qventus, the leader in AI-driven care operations automation, today released its second annual report on how health system CIOs are adopting and scaling AI: Beyond the Pilot: How CIOs Are Operationalizing AI Across Health Systems in 2026. The findings come from a survey and 1:1 interviews with more than 60 CIOs, Chief AI Officers, CMIOs, and other senior IT leaders at medium and large health systems. The report reveals the latest approaches to AI adoption, barrier...
-

Ravin Consultants Announces Next Chapter of Leadership

BRADENTON, Fla.--(BUSINESS WIRE)--Ravin Consultants names Dr. Robert Ferraro CEO as Founder Jennifer Lockwood becomes Executive Chair, supporting growth in a complex 340B landscape....
-

Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS

HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the publication of a research study led by Dr. David Beers and Dr. Stanley Appel at the Houston Methodist Neurological Institute. The study included the longitudinal measurement of well-characterized serum biomarkers of lipid peroxidation (4-hydroxy-2-nonenal [4-HNE]), systemic inflammation (lipopolys...
-

Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference

BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that Company management will present at the 25th Annual Needham Virtual Healthcare Conference on Thursday, April 16th, 2026 at 12:45 p.m. ET. The live webcast of the presentation may be accessed via the Events and Presentations section of the Sensei website at investors.senseibio.com. A replay of the webcast will be available for approximately 90 days following the event. About Sensei Biotherapeutics Sensei Bio...
-

NEUPATH HEALTH TO PRESENT AT THE 2026 BLOOM BURTON & CO. HEALTHCARE INVESTOR CONFERENCE

TORONTO--(BUSINESS WIRE)--NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”) operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic pain, musculoskeletal/back pain, sports medicine and other pain medical services markets, today announced that Stephen Lemieux, CEO, will present and participate in one-on-one meetings at the 2026 Bloom Burton & Co. Healthcare Investor Conference to be held...